PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31434198-1	2019	Linagliptin is a representative of dipeptidyl peptidase 4 (DPP-4) inhibitors which are registered and used effectively in a treatment of diabetes mellitus type 2.	Linagliptin	0-11	dipeptidylpeptidase 4	Rattus norvegicus	35-57	
31434198-1	2019	Linagliptin is a representative of dipeptidyl peptidase 4 (DPP-4) inhibitors which are registered and used effectively in a treatment of diabetes mellitus type 2.	Linagliptin	0-11	dipeptidylpeptidase 4	Rattus norvegicus	59-64	
31434198-4	2019	Linagliptin"s administration leads to a decrease in the concentration of proinflammatory factors such as: TNF-alpha, IL-6 and increases the number of anti-inflammatory patrolling monocytes CX3CR1bright.	Linagliptin	0-11	tumor necrosis factor	Rattus norvegicus	106-115	
31434198-4	2019	Linagliptin"s administration leads to a decrease in the concentration of proinflammatory factors such as: TNF-alpha, IL-6 and increases the number of anti-inflammatory patrolling monocytes CX3CR1bright.	Linagliptin	0-11	interleukin 6	Rattus norvegicus	117-121	
31434198-4	2019	Linagliptin"s administration leads to a decrease in the concentration of proinflammatory factors such as: TNF-alpha, IL-6 and increases the number of anti-inflammatory patrolling monocytes CX3CR1bright.	Linagliptin	0-11	C-X3-C motif chemokine receptor 1	Rattus norvegicus	189-195	
31434198-6	2019	Linagliptin improved vascular functions by increasing production of nitric oxide (NO) and limiting concentration of apolipoprotein B.	Linagliptin	0-11	apolipoprotein B	Rattus norvegicus	116-132	
31434198-10	2019	Linagliptin prevented abnormal proliferation and migration of rat brain microvascular endothelial cells in a state of hypoperfusion via SIRT1/HIF-1alpha/VEGF pathway.	Linagliptin	0-11	sirtuin 1	Rattus norvegicus	136-141	
31434198-10	2019	Linagliptin prevented abnormal proliferation and migration of rat brain microvascular endothelial cells in a state of hypoperfusion via SIRT1/HIF-1alpha/VEGF pathway.	Linagliptin	0-11	hypoxia inducible factor 1 subunit alpha	Rattus norvegicus	142-152	
31434198-10	2019	Linagliptin prevented abnormal proliferation and migration of rat brain microvascular endothelial cells in a state of hypoperfusion via SIRT1/HIF-1alpha/VEGF pathway.	Linagliptin	0-11	vascular endothelial growth factor A	Rattus norvegicus	153-157